Singapore-based biotechnology company Mirxes is still considering listing itself on the Singapore Stock Exchange (SGX), after it filed for an IPO on the Hong Kong Exchanges and Clearing (HKEX) last week, according to a report by The Straits Times on Friday.
Register now to enjoy 3 free articles per month,
or log in to continue reading.
Stay informed with complimentary articles each month
Gain access to our exclusive newsletters delivered directly to your inbox
Be the first to know about all our summits!
Already a Subscriber? Log in
